NEW YORK, Sept. 4-The federal Defense Advanced Research Projects Agency awarded U.S. Genomics nearly $500,000 to adapt its linear DNA analysis technology for pathogen detection, the company said today.
With the grant, U.S. Genomics will determine how its GeneEngine technology might be used for rapid detection and identification of infectious agents. Such a system could be useful in counteracting a biological warfare, the company said.